{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01375",
      "entity_text" : "TNF-alpha",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00523",
      "entity_text" : "Infliximab",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The TNF-alpha blocker Infliximab is known to improve the course and prognosis of acute severe UC and reduce colectomy rates 27.",
  "reading_complete" : "2020-08-05T18:57:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T18:56:18Z",
  "trigger" : "blocker",
  "evidence" : [ "TNF-alpha blocker Infliximab" ],
  "pmc_id" : "7292621",
  "score" : 0
}